International Journal of Radiation Oncology * Biology * Physics
Volume 28, Issue 1 , Pages 23-31 , 1 January 1994

Prostate-specific antigen kinetics after external beam irradiation for carcinoma of the prostate

  • Richard S. Cox, Ph.D.

      Affiliations

    • Corresponding Author InformationReprint request to: Richard S. Cox, Ph.D.
    • Department of Radiation Oncology, Stanford University School of Medicine, Stanford, CA, USA
    • ,
  • Irving D. Kaplan, M.D.

      Affiliations

    • Joint Center for Radiation Therapy, Harvard Medical School, Boston, MA, USA
    • ,
  • Malcolm A. Bagshaw, M.D.

      Affiliations

    • Department of Radiation Oncology, Stanford University School of Medicine, Stanford, CA, USA

,Accepted 1 June 1993.

References 

  1. American Joint Commission on Staging of Cancer . In: 2nd ed.. Manual for staging of cancer. Philadelphia, PA: Lippincott; 1992;
  2. Bagshaw MA. Carcinoma of the prostate. In:  Levitt SH,  Kahn FM,  Potish RA editor. Levitt and Tapley's technological basis of radiation therapy: Practical clinical applications. 2nd ed.. Philadelphia PA: Lea and Febiger; 1992;p. 300–330
  3. Catalona WJ, Smith DS, Ranliff TL. Measurement of prostate-specific antigen in serum as a screening test for prostate cancer. N. Engl. J. Med. 1991;324:1156–1161
  4. Cox DR. Analysis of binary data. London: Chapman and Hall; 1970;
  5. Cox DR. Regression models and life tables. J. Royal Stat. Soc. B. 1972;34:87–220
  6. Dundas GS, Porter AT, Venner PM. Prostate-specific antigen: Monitoring the responce of carcinoma of the prostate to radiotherapy with a new tumor marker. Cancer. 1990;66:45–48
  7. Gehan EA. A generalized Wilcoxon test for comparing arbitrarily singly censored samples. Biometrica. 1965;52:203–233
  8. Gleason DF. The Veterans Administration Cooperative Urological Research Group. Histological grading and clinical staging of prostatic carcinoma. In:  Tennenbaum M editors. Urologic pathology: The prostate. Philadelphia, PA: Lea and Febinger; 1977;p. 171–197
  9. Graves HCB, Wehner N, Stamey TA. Comparison of a polyclonal and monoclonal immunoassay for PSA: Need for an international standard. J. Urol. 1990;144:1516–1520
  10. Hosmer D, Lemeshow S. Goodness-of-fit tests for the multiple logistic regression model. Commun. Statist. — Part A Theor. Meth. 1980;A9(10):1043–1069
  11. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J. Am. Statist. Assoc. 1958;53:457–481
  12. Kaplan I, Prestidge BR, Cox RS, Bagshaw MA. Prostate specific antigen after irradiation for prostatic carcinoma. J. Urol. 1990;144:1172–1175
  13. Kaplan ID, Cox RS, Bagshaw MA. A model of prostatic carcinoma tumor kinetics based on prostate specific antigen levels after radiation therapy. Cancer. 1991;68:400–405
  14. Kaplan ID, Cox RS, Bagshaw MA. Prostate specific antigen after external beam irradiation: Follow-up. J. Urol. 1993;149:519–522
  15. Killian CS, Yang N, Emrich LJ, Vargas FP, Kuriyama M, Wang MC, et al. Prognostic importance of prostatespecific antigen for monitoring patients with stage B2 and D1 prostate cancer. Cancer Res. 1985;45:886–891
  16. Landmann C, Hunig R. Prostate specific antigen as an indicator of response to radiotherapy in prostate cancer. Int. J. Radiat. Oncol. Biol. Phys. 1989;17:1073–1076
  17. Mellinger GT, Gleason D, Bailer J. The histology and prognosis in carcinoma of the prostate. Front. Radiat. Ther. Oncol. 1967;9:267–273
  18. Mendenhall W. Introduction to probability and statistics. Belmont, CA: Wadsworth Publishing Co., Inc; 1979;
  19. Ritter MA, Messing EM, Shanahan TG, Potts S, Chappell RJ, Kinsella TJ. Prostate-specific antigen as a predictor of radiotherapy response and patterns of failure in localized prostate cancer. J. Clin. Oncol. 1992;10:1208–1217
  20. Russell KJ, Dunatov C, Hafferman MD, Griffeth JT, Polissar GL, Pelton J, et al. Prostate specific antigen in the management of patients treated with primary radiation therapy. J. Urol. 1991;146:1046–1052
  21. Stamey TA, Yang N, Hay AR. Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate. N. Engl. J. Med. 1991;317:909–916
  22. Zagars GK, Sherman NE, Babaian RJ. Prostatespecific antigen and external beam radiation therapy in prostate cancer. Cancer. 1991;67:412–420

PII: 0360-3016(94)90137-6

doi: 10.1016/0360-3016(94)90137-6

International Journal of Radiation Oncology * Biology * Physics
Volume 28, Issue 1 , Pages 23-31 , 1 January 1994

Article Tools